Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis
This study has been completed.
Study NCT00092742   Information provided by Merck
First Received: September 23, 2004   Last Updated: April 27, 2009   History of Changes

September 23, 2004
April 27, 2009
February 2003
 
Discontinuations due to clinical and laboratory gastrointestinal adverse experiences
Same as current
Complete list of historical versions of study NCT00092742 on ClinicalTrials.gov Archive Site
 
 
 
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis
A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 75 mg b.i.d. in Patients With Rheumatoid Arthritis

The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.

The duration of treatment is 12 months.

Phase III
Interventional
Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Safety Study
Rheumatoid Arthritis
  • Drug: MK0663, etoricoxib
  • Drug: Comparator: Diclofenac sodium
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
4000
 
 

Inclusion Criteria:

  • Males and females 50 years or older with rheumatoid arthritis.

Exclusion Criteria:

  • History of gastrointestinal malabsorption or inflammatory bowel disease
  • History of heart problems such as: congestive heart failure (CHF), heart attack or high blood pressure.
Both
50 Years and older
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00092742
Executive Vice President, Clinical and Quantitative Sciences, Merck & Co., Inc.
2004_055, MK0663-072
Merck
 
Study Director: Medical Monitor Merck
Merck
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP